Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis

¹Eastern Virginia Medical School, Division of Dermatology, Norfolk 23507.

|July 1, 1994

Abstract:

Four hundred and ten subjects were enrolled in a randomized, double-blind, parallel vehicle-controlled study to confirm the effectiveness and safety of topically applied oxiconazole nitrate (Oxistat) lotion, 1 percent, used once or twice daily in the treatment of tinea pedis.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

Journal of patient-reported outcomes·2019

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

The British journal of dermatology·2017

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.

The British journal of dermatology·2015

See all related articles

Related Experiment Videos

Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis

Related Concept Videos

Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study.

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.

Association Between Hidradenitis Suppurativa and Polycystic Ovary Syndrome.

Medical Decision-Making in Evaluation and Management Coding: Practical Applications and Key Clarifications.

Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation.

Getting a Grip on Occupational Hand Dermatitis: Key Considerations for Evaluation and Management.

Horse Flies: Identification, Bite Reactions, and Clinical Management.

Pembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment Resistance.

Related Experiment Videos

Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis

Abstract:

Related Concept Videos

Related Articles